Drug Trial Radar · NCT06669091
Food-effect Study of Ecopipam Pharmacokinetics
Last checked: Nov 19, 2026Latest source record: Jan 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Nov 5, 2024
Primary completion
Dec 22, 2024
Study completion Dec 27, 2024
Sponsor
- Lead sponsor
- Emalex Biosciences Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Standard food-effect study to identify the effect of food on ecopipam pharmacokinetics after administration of a to-be-marketed ecopipam tablet in healthy volunteers.
Conditions
- Food-effect
Interventions
Ecopipam tabletDrug
A single ecopipam 89.6 mg tablet (equivalent to ecopipam HCl 100 mg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
- Tmax of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
- AUC of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
- AUCinf of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
- AUClast of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
- Cmax of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
- Tmax of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
- AUC of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
- AUClast of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
- AUCinf of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ICON Early Phase Services
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.